PMD17 - Burden Disease of Aortic Stenosis Associated in Patients Undergoing Transcatheter Aortic Valve Replacement

Abstract

To estimate the cost and length of stay (LOS) of aortic stenosis (AS) with transcatheter aortic valve replacement (TAVR) An administrative claims database containing over 18 million lives (ORIZON, Brazilian Private Health Care, Fee-for-service) was assessed (from jan/2015 until dec/2016), of patients who underwent a transcatheter aortic valve replacement (n=84) . Records showed expenditure with material, tax, procedures, medication and diagnostics. The average and median with confidence interval of 95% was adopted. 84 patients made use of TAVI and had complete index hospital bills available (the treatment in Brazil are approval only for inoperable and high-risk patients) . The averange cost per patient was BRL 231,972 (include the valve and complications), the cost per day was BRL 9,896 (IC95% 5,579 -14,213), and the median LOS was 16 days. Almost 55% of cost was related with other expenses (tax, procedure, others materials and medications. Most of the treatment cost were not related with Device for this reason the avoidance clinical complications should improve the LOS and cost treatment of TAVR for high-risk and inoperable patients.